ENDRA Life Sciences Inc. — Director's Dealing 2021

Apr 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2021-04-05

Reporting Person: Tokman Alexander Y (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-05	Stock Options	$2.64	A	25000	Acquired	2031-04-05	Common Stock (25000)	Direct

Footnotes

F1: This stock option grant becomes exercisable in three equal annual installments beginning April 5, 2022.